These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36294870)

  • 1. Identification of Potential Repurposable Drugs in Alzheimer's Disease Exploiting a Bioinformatics Analysis.
    Fiscon G; Sibilio P; Funari A; Conte F; Paci P
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs.
    Fagone P; Mangano K; Martino G; Quattropani MC; Pennisi M; Bella R; Fisicaro F; Nicoletti F; Petralia MC
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potentially Repurposable Drugs for Lewy Body Dementia Using a Network-Based Approach.
    Manoj M; Sowmyanarayan S; Kowshik AV; Chatterjee J
    J Mol Neurosci; 2024 Feb; 74(1):21. PubMed ID: 38363395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
    G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
    Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
    Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
    Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network-based stage-specific drug repurposing for Alzheimer's disease.
    Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
    Comput Struct Biotechnol J; 2022; 20():1427-1438. PubMed ID: 35386099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Comorbidity Knowledge for Alzheimer's Disease Drug Repurposing using Multi-task Graph Neural Network.
    Lin KH; Hsieh KL; Jiang X; Kim Y
    AMIA Jt Summits Transl Sci Proc; 2023; 2023():378-387. PubMed ID: 37350918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential Driver Genes and Pathways Based on Transcriptomics Data in Alzheimer's Disease.
    Xia LY; Tang L; Huang H; Luo J
    Front Aging Neurosci; 2022; 14():752858. PubMed ID: 35401145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
    Advani D; Kumar P
    ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review.
    Grabowska ME; Huang A; Wen Z; Li B; Wei WQ
    Front Pharmacol; 2023; 14():1257700. PubMed ID: 37745051
    [No Abstract]   [Full Text] [Related]  

  • 15. Reappraisal of FDA approved drugs against Alzheimer's disease based on differential gene expression and protein interaction network analysis: an in silico approach.
    G N S HS; Ganesan Rajalekshmi S; Murahari M; Burri RR
    J Biomol Struct Dyn; 2020 Aug; 38(13):3972-3989. PubMed ID: 31543038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Ligands with Glycogen Synthase Kinase 3 Inhibitory Activity as a New Direction in Drug Research for Alzheimer's Disease.
    Jankowska A; Satała G; Bojarski AJ; Pawłowski M; Chłoń-Rzepa G
    Curr Med Chem; 2021; 28(9):1731-1745. PubMed ID: 32338201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug.
    Hughes RE; Nikolic K; Ramsay RR
    Front Neurosci; 2016; 10():177. PubMed ID: 27199640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases.
    Fiscon G; Conte F; Farina L; Paci P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409062
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.